V Wealth Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

V Wealth Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,515	Closed	-$224K	–	270
2018 Q4	$224K	Hold	14,515	–	–	0.11%	191
2018 Q3	$224K	Sell	14,515 -1,603	-10%	-$25.3K	0.1%	200
2018 Q2	$258K	Buy	+16,118	New	+$239K	0.14%	164
2017 Q4	–	Sell	-19,792	Closed	-$269K	–	217
2017 Q3	$269K	Hold	19,792	–	–	0.14%	148
2017 Q2	$313K	Buy	+19,792	New	+$288K	0.15%	128

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

V Wealth Advisors's IRWD Position: Q1 2019 in Review

V Wealth Advisors sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2019, closing a stake of 14,515 shares — an estimated $224K sold.

V Wealth Advisors first reported a position in IRWD in Q2 2017 and held it in 5 quarters. The position peaked at $313K in Q2 2017. 156 funds tracked by Wall St. Rank hold IRWD as of Q1 2019.

V Wealth Advisors reported no remaining Ironwood Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
V Wealth Advisors sold 14,515 Ironwood Pharmaceuticals shares in Q1 2019, an estimated $224K.
V Wealth Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2017 and held it in 5 quarters.
V Wealth Advisors's Ironwood Pharmaceuticals position peaked at $313K in Q2 2017.
156 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2019.

Based on V Wealth Advisors's 13F filing for Q1 2019, filed 16 May 2019.